Non-Tariff Barriers

Non-Tariff Measure

NTM classification

B31: Labelling requirements 

Date when the measure came into force

29 December 2000 

Publication where the measure is specified

Act No. 41 of 2000 

Regulation where the measure is specified

Dangerous Drugs Act 2000 

Country/Region applying the measure

Mauritius 

The rationale of the measure

None specified 

Coded list of objectives

X: For purposes n.e.s. 

Description of the measure

20. Packaging and labelling
(1) Subject to subsection (2), no person shall supply a dangerous drug otherwise than in a container labelled -
(a) in the case of a powder, solution or ointment, with the total quantity of the dangerous drug supplied and the percentage of the dangerous drug contained in it;
(b) in the case of tablets and other articles, with the total quantity of the dangerous drug contained in the tablet or article;
(c) in the case of substances and preparations listed in Schedule II, a double red band.
(2) Subsection (1) shall not apply to a dangerous drug dispensed by, or on the prescription of, a medical practitioner, dental surgeon or veterinary surgeon.
(3) The outer wrapping of parcels for consignment containing dangerous drugs shall bear no information other than the names and addresses of the sender and the consignee and shall be sealed with the sender's mark. 

Reference of the measure

Article 20 

Measure also domestic

Yes 

Products affected by the measure.

Description

"dangerous drug" means -
(a) any plant or part thereof or substance listed in Schedule I, II or III;
(b) the isomers of the listed drugs, unless specifically excepted, whenever the existence
of such isomersis possible within the specific chemical designation;
(c) the esters and ethers of the drugs listed in Schedule 1,11 or III, whenever their
existence is possible-
(d) the salts esters of the drugs listed in Schedule I, II or III, including the salts of ethers
and isomers whenever the existence of such salts is possible; the preparations of these
substances, other than those listed in Schedule V;

SCHEDULE I

Part I
Amfetamine
Cannabis (also named as Gandia or Indian Hemp)
Dexamtetamine
Fenetylline
Meeloqualone
Methaqualone
Methylphenidate
Secobarbital
Khat
[Inserted GN 179/15 (cio 11/9/15).]
Lisdexamphetamine
[Inserted GN 179/15 (cio 11/9/15).]
Methoxetamine
[Inserted GN 179/15 (cio 11/9/15).]
N-benzylpiperazine (also named BZP)
[Inserted GN 179/15 (cio 11/9/15).]


Part II
Acetyl-alphamethylfentanyl
Alphacetylmethadol
Alpha-methylfentanyl
Beda-hydroxyfentanyl
Beta-hydroxy-3-
methylfentanyl
Brolamfetamine
Cannabis Resin
Cathinone
Coca bush Coca leaf
Cocaine
Concentrate of Poppy
Straw
Desmorphine
DET
DMA
DMHPDMT
DOET
Ecgonine, its esters and
derivatives
Eticyclidine
Etorphine
Etryptamine
Heroin
Ketobemidone
Levamfetamine
Levomethamphetamine
(+) ˆ Lysergide
MDMA
Mescaline
Metamfetamine
Metamfetamine
Racemate
Metheathinone
4-methylaminorex
3-methylfentanyl
3-methylthiofentanyl
MMDA
MPPP
N-ethyl MDA
N-hydroxy MDA
opium
Opium Poppy
Oronabinol
Parafluorofentanyl
Parahexyl
PCE
PCPY
PEPAPPHP
Phencyclidine
PhenmetrazinePMA
Psilocine
Psilocybine
Psilotsin
Rolicyclidine
STP, DOMTCP
Tenamfetamine
Tenocyclidine
Thiofentanyl
TMA
Zipeprol

Synthetic Cannabinoids and their derivatives
[Inserted GN 242/13 (cio 10/10/13).]Synthethic Cathinones, their chemical diversities and derivatives including –
4-Fluoromethcathinone (also named flephedrone or 4-FMC)
Synthethic Cathinones, their chemical diversities and derivatives including –

4-Fluoromethcathinone (also named flephedrone or 4-FMC)

4-Methyl cathinone (also named mephedrone)

4-Methylmethcathinone (also named 4MMC)

3,4-Methylenedioxypyrovalerone (also named MDPV)

4-Methylethcathinone (also named 4 MEC)

Methylone (also named bk–MDMA)

[Inserted GN 179/15 (cio 11/9/15).]

4-Tetrahydrocannabinol (also named 4THC)
[Inserted GN 179/15 (cio 11/9/15).]



SCHEDULE II

Acetyldihydrocodeine Drotebanol Norcodeine
Acetylmethadot Ethylmethilthiambutene Norlevorphanol
Alfentanit Ethylmorphine Normethadone
Allylprodine Etonitazene Normorphine
Alpharneprodine Etoxeridine Norpipanone
Alphamethadol Fentanyt Oxycodone
Alpha-methylthiofentanyl Furethidine Oxymorphone
Alphaprodine Hydrocodone Pethidine
Anileridine Hydromorphinol Pethidine-Intermediate A
Benzyimorphine Hydroxypethidine Pethidine-Intermediate B
Betameprodine Levomethorphan Pethidine-Intermediate C
Betaprodine Levophenacylmorphan Phenadoxone
Bezitrarnide Levorphanol Phenarnpromide
Buprenorphine Metazocine Phenazocine
Clonitazene Methadone Phenomorphan
Codeine Methadone-Inten-nediate Phenoperidine
Codoxime
Methyidesorphine
Pholcodine
Dextrornoramide
Methyidihydromorphine
Piminodine
Dextropropoxyphene
Metopon
Piritramide
Diampromide
Moramide-Interrnediate
Proheptazine
Diethylthiarnbutene
Morpheridine
Properidine
Difenoxin
Morphine
Propiram
Dihydrocodeine
Morphine
Methobromide
Racemethorphan
Dihydromorphine
Morphine-N-Oxide
Racemoramide
Dimenoxadol
Myrophine
Racemorphan
Dimephepatanot
Nicocodine
Sufentanit
Dimethylthiarnbutene
Nicodicodine
Thebacon
Dioxaphetylbutyrate
Nicomorphine
Thebaine
Diphenoxylate
Noracymethadol
Tilidine
Dipipanone
Trimeperidine
Flunitrazepam
[Inserted GN 179/15 (cio 11/9/15).]


SCHEDULE III

Allobarbital
Etilamfetamine
Nimetazepam
Alprazolam'
Fencamfarrnin
Nitrazepam
Amfepramone
Fenproporex
Nordazepam
Aminorex
Fludiazepam
Oxazepam
Amobarbital
Flunitrazepam
Oxazolam
Barbital
Flurazepam
Pemoline
Benzfetamine
Glutethimide
Pentazocine
Bromazepam
Haloxazolam
Pentobarbital
Brotizolam
Ketazolam
Phendimetrazine
Butalbital
Lefetamine
Phenobarbital
Butobarbital
Loprazolam
Phentermine
Camazepam
Lorazepam
Pinazepam
Cathine
Lorrnetazepam
Prazepam
Chlordiazepoxide
Mazindot
Pyrovalerone
Clobazam
Medazepam
Secbutabarbital
Clobenzofex
Mefenorex
Temazepam
Clonazepam
Meprobamate
Tetrazepam
Clorazepate
Mesocarb
Tramadol
Clotiazepam
Methylphenobarbital
Triazolam
Cloxazolam
Methyprylon
Vinylbital
Cyclobarbital
Midazolam
Zolpidem
Delorazepam
Zopiclone
Diazepam
Estazolam
Ethchlorvynol
Ethinamate
Ethyl Loflazepate
Pregabalin (its chemical diversities, including its derivatives and related substance)
[Inserted GN 179/15 (cio 11/9/15).] 

Countries/Regions affected by the measure.

Description

Entire world